 |
|
 |
 |
|
Resources for Myelodysplasia & Myeloproliferative Disorders
|  | | Contents |  | 
|  | | The Myelodysplastic Syndromes (MDS) |
 |
MDS Include:
- Refractory Anemia
- Refractory Anemia with Sideroblasts
- Refractory Anemia with Excess Blasts
- Chronic Myelomonocytic Leukemia
- Refractory
Anemia with Excess Blasts in Transformation
- Preleukemia
including Aplastic Anemia caused by environmental
exposure
- PH negative Chronic Myelocytic Leukemia
Myelodysplastic Syndromes (MDS) Resources
- The NCI PDQ patient statement on Myelodysplastic Syndromes (or myelodysplasia).
- The NCI PDQ physician statement on Myelodysplastic Syndromes (or myelodysplasia) .
- Bone Marrow Transplants for Myelodysplastic Syndrome from BMT Newsletter, September 1995, Issue #31.
- Myelodysplastic Syndromes Basic Explanations (PDF) from the Aplastic Anemia and MDS International Foundation (formerly The Aplastic Anemia Foundation of America). This document is in a PDF document which you can download and view . You will need Adobe Acrobat Reader to view these documents. If you do not have it you can download the Adobe Acrobat Reader.
- Myelodysplastic Syndromes, by Moshe Talpaz, et. al. This is Continuing Medical Education (CME) course from Medscape, intended for doctors. It provides an overview of the Myelodysplastic Syndromes, their diagnosis and treatment.
- Myelodysplastic Syndromes in the Elderly by Hussain I. Saba, from Cancer Control: Journal of the Moffitt Cancer Center, Vol 8, No. 1, 2001. This article is a review of the diagnosis, prognosis and treatment of the Myelodysplastic Syndromes, not just in all adults, not just the elderly.
- Myelodysplastic syndrome by Emmanuel C Besa, MD and Ulrich Woermann, MD, from the eMedicine World Medicine Library. This is a very technical review of the symptoms, causes, diagnosis and treatment of adult MDS.
- Myelodysplasia by Sharon M Castellino, MD, and Carmen Arkansas, MD from the eMedicine World Medicine Library. This is a very technical review of the symptoms, causes, diagnosis and treatment of pediatric MDS .
-
Myelodysplastic Syndromes by Alan F. List, James
Vardiman, Jean-Pierre J. Issa and Theo M. DeWitte, from Hematology ,
American Society of Hematology Education Program Book
, 2004. Increased understanding of the natural
history and biology of MDS has lead to the development of treatments
and better understanding of the progosis for the
different types of MDS. This article provides an
overview of recent developments in the characterization of MDS and how
these findings have lead to new promising treatments.
 |  | | The Myeloproliferative Disorders
(MPD) |  |
MPD includes:
- Polycythemia Vera
- Chronic
Myelogenous Leukemia (PH positive)
- Agnogenic
Myeloid Metaplasia (Myelofibrosis)
- Essential
Thrombocythemia
MPD Resources
- The NCI PDQ
patient statement on Myeloproliferative Disorders
- The NCI PDQ
physician statement on Myeloproliferative
Disorders
- Home Page of the
Myeloproliferative Disorders Institute. The
following FAQs are from the Myeloproliferative Disorders
Institute:
-
Below you will find reviews on the
Myeloproliferative Diseases from eMedicine
World Medicine Library. These reviews are very
technical and cover the symptoms, causes, diagnosis and
treatment of the MPDs.
-
Myeloproliferative Disease by Haleem Rasool,
MD, and Donald Doll, MD.
-
Agnogenic Myeloid Metaplasia with
Myelofibrosis by Asheesh Lal, MBBS
-
Chronic Myelogenous Leukemia by Emmanuel C
Besa, MD and Ulrich Woermann, MD.
-
Essential thrombocytosis, by Asheesh Lal,
MBBS.
-
Polycythemia Vera by Emmanuel C Besa, MD and Ulrich Woermann, MD.
-
Myelofibrosis by J Martin Johnston, MD, this
article is on pediatric Myelofibrosis .
- The Center for the Chronic
Myeloproliferative Disorders of Johns Hopkins
Oncology Center.
-
The first State Of The Science (SOTS) meeting on the
Myeloproliferative Disorders (MPDs) and Mastocytosis was held April
29, 2002. It yielded recommendations for further research and how to
advance the research into these diseases. This site includes lecture
notes and slides for the various sessions.
-
Chronic Myelogenous Leukemia and
Myeloproliferative Disease by Stephen O'Brien,
Ayalew Tefferi and Peter Valent, Hematology,
American Society of Hematology Education Program
Book, 2004. Reviews the latest data on the use of
imatinib (Gleevec) in CML, including response data and
resistance and its use in combinaton with other drugs.
The biology and treatment of myelofibrosis and the
classificatoin of mast cell proliferative disorders are
also reviewed.
Disclaimer
|
|